ACN MedUpdate: Your Monthly Health & Practice Snapshot
- Sep 28
 - 1 min read
 
Interstitial Lung Disease Diagnosis Can’t Wait
September is Pulmonary Fibrosis Awareness Month
Pulmonary Fibrosis (PF) in Context:
Pulmonary fibrosis is a significant threat within interstitial lung diseases (ILDs), a diverse group of lung disorders:
Idiopathic ILD
Autoimmune ILDs
Sarcoidosis
Hypersensitivity pneumonitis
Other ILDs
Fact: Idiopathic pulmonary fibrosis (IPF) is the most common form.
Why Early Recognition Matters - PF can progress rapidly and is linked to poor prognosis. Watch for:
Worsening respiratory symptoms
Decline in lung function (FVC decreases)
Increased mortality or risk for lung transplantation
Common Diagnostic Challenges:
PF often mimics other respiratory conditions due to nonspecific symptoms:
Symptoms: Cough, dyspnea, fatigue
Frequently misdiagnosed as: COPD, bronchitis, emphysema, asthma, CHF.
Tips for Accurate Diagnosis
Order a High-Resolution CT (HRCT) scan
Include key clinical details in your order:
Non-productive or dry cough
Dyspnea
Crackles on auscultation
Fatigue/weakness
Finger clubbing
Unexplained weight loss or loss of appetite
Treatment Updates
FDA-approved antifibrotic therapies can slow disease progression.
Takeaway: Early identification and timely treatment are essential for improved outcomes.
Earn 6.5 CME credits about Interstitial Lung Disease offered by Boehringer Ingelheim Pharmaceuticals, Inc.
Date: October 4, 2025
Location: Lake Buena Vista, FL
References:
Disclaimer: This information is intended solely for educational purposes and should not be considered a substitute for professional medical judgment or personalized patient care. Clinicians must refer to official guidelines, original research, and institutional protocols before making clinical decisions. ACN is not responsible for the accuracy or completeness of this content.

Comments